Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2Sharad K. Verma, William H. Miller, Xinrong Tian et al.|ACS Medicinal Chemistry Letters|2012Cited by 377
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D. Knight, Dashyant Dhanak, Nicholas D. Adams et al.|ACS Medicinal Chemistry Letters|2010Cited by 374
A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) HypertrimethylationHeidi M. Ott, Michael T. McCabe, Wendy S. Halsey et al.|Molecular Cancer Therapeutics|2014Cited by 46
221 POSTER A novel inhibitor of phosphoinositide 3-kinase for the treatment of cancerK R Auger, Dashyant Dhanak, Liang Luo et al.|European Journal of Cancer Supplements|2008Cited by 5
Abstract C62: Identification of GSK2126458, a highly potent inhibitor of phosphoinositide 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR)Steven D. Knight, Dashyant Dhanak, Nicholas D. Adams et al.|Molecular Cancer Therapeutics|2009Cited by 4